Evidence map›Paper›PMID 30210574›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2018

Organic Extract of

Tiago Rafael de Sousa Nunes, Marina Ferraz Cordeiro, Fernanda Gomes Beserra, Matheus Landim de Souza, Wliana Alves Viturino da Silva, Magda Rhayanny Assunção Ferreira, Luiz Alberto Lira Soares, Sérgio Dias Costa-Junior, Isabella Macário Ferro Cavalcanti, Maira Galdino da Rocha Pitta and 2 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Overview of theMolecules (Basel, Switzerland) · 2023
    Review
  4. Analysis of Carbapenemase-Resistant Genotypes of Highly VirulentEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Tiago Rafael de Sousa NunesLaboratory of Immunomodulation and New Therapeutical Approaches, Research Centre for Therapeutic Innovation-SuelyGaldino (NUPIT-SG), Federal University of Pernambuco, Recife, PE, Brazil.
Marina Ferraz CordeiroLaboratory of Immunomodulation and New Therapeutical Approaches, Research Centre for Therapeutic Innovation-SuelyGaldino (NUPIT-SG), Federal University of Pernambuco, Recife, PE, Brazil.
Fernanda Gomes BeserraLaboratory of Immunomodulation and New Therapeutical Approaches, Research Centre for Therapeutic Innovation-SuelyGaldino (NUPIT-SG), Federal University of Pernambuco, Recife, PE, Brazil.
Matheus Landim de SouzaLaboratory of Immunomodulation and New Therapeutical Approaches, Research Centre for Therapeutic Innovation-SuelyGaldino (NUPIT-SG), Federal University of Pernambuco, Recife, PE, Brazil.
Wliana Alves Viturino da SilvaLaboratory of Pharmacognosy, Department of Pharmaceutical Sciences, Federal University of Pernambuco, Recife, PE, Brazil.
Magda Rhayanny Assunção FerreiraLaboratory of Pharmacognosy, Department of Pharmaceutical Sciences, Federal University of Pernambuco, Recife, PE, Brazil.ORCID 0000-0001-8668-6223
Luiz Alberto Lira SoaresLaboratory of Pharmacognosy, Department of Pharmaceutical Sciences, Federal University of Pernambuco, Recife, PE, Brazil.
Sérgio Dias Costa-JuniorLaboratory of Immunopathology KeizoAsami (LIKA), Federal University of Pernambuco, Recife, PE, Brazil.
Isabella Macário Ferro CavalcantiLaboratory of Immunopathology KeizoAsami (LIKA), Federal University of Pernambuco, Recife, PE, Brazil.
Maira Galdino da Rocha PittaLaboratory of Immunomodulation and New Therapeutical Approaches, Research Centre for Therapeutic Innovation-SuelyGaldino (NUPIT-SG), Federal University of Pernambuco, Recife, PE, Brazil.ORCID 0000-0001-5881-0338
Ivan da Rocha PittaLaboratory of Immunomodulation and New Therapeutical Approaches, Research Centre for Therapeutic Innovation-SuelyGaldino (NUPIT-SG), Federal University of Pernambuco, Recife, PE, Brazil.
Moacyr Jesus Barreto de Melo RêgoLaboratory of Immunomodulation and New Therapeutical Approaches, Research Centre for Therapeutic Innovation-SuelyGaldino (NUPIT-SG), Federal University of Pernambuco, Recife, PE, Brazil.ORCID 0000-0002-1883-6012
Universidade Federal de Pernambuco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID30210574
PMCPMC6126107
OpenAlexW2888218122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.